Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Gene Therapeutics & RNAi

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1339884

Cover Image

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1339884

RNA Targeting Small Molecule Drug Discovery Market with COVID-19 Impact Analysis, By Indication, By Drug, By Route of Administration, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

PUBLISHED:
PAGES: 311 Pages
DELIVERY TIME: 2-3 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 3250
PDF (5 User License)
USD 4650
PDF (Enterprise User License)
USD 5650

Add to Cart

Description

Table of Contents

List of Tables

REPORT HIGHLIGHT

RNA targeting small molecule drug discovery Market size was valued at USD 1,208.1 Million in 2022, expanding at a CAGR of 21.8% from 2023 to 2030.

RNA targeting small molecules drug discovery refers to the process of examining and developing small molecule drugs that specifically inhibit and modulate the function of RNA molecules within cells. RNA, or ribonucleic acid, plays an essential role in several cellular processes, including regulation and gene expression. Moreover, a tiny molecule is an organic compound with a relatively low, molecular weight that can interact with biological targets including nucleic acids or proteins.

RNA Targeting Small Molecule Drug Discovery Market- Market Dynamics:

  • Several novel techniques and the healthcare sector raising the market demand.
  • To expand the drug ability of RNA molecules various novel techniques have been developed. As a result, numerous small molecules, with the potential of acting on current and novel RNA targets are also being studied in preclinical and clinical studies for the treatment of several indications, including infectious diseases, genetic diseases, and other types of cancers. Thus, such factors may drive the demand for the RNA targeting small molecules drug discovery market. However, the exorbitant cost of medication research is one of the main obstacles to the market growth. Moreover, it is projected that the RNA targeting small molecules drug discovery industry could transform the way the healthcare sector currently treats various diseases. In line with this, these drugs function by selectively targeting RNA molecules, which are appealing targets for drug development as they are important for controlling gene expression.

RNA Targeting Small Molecule Drug Discovery Market- Key Insights:

  • As per the analysis shared by our research analyst, the global RNA targeting small molecule drug discovery market is estimated to grow annually at a CAGR of around 21.8% over the forecast period (2023-2030)
  • This market pioneers the development of drugs that selectively target RNA, presenting a promising approach to tackle diseases with unmet medical needs, such as genetic disorders and certain cancers.
  • RNA-targeted small molecules offer new dimensions to drug discovery, complementing traditional approaches and broadening the scope of treatable conditions, ultimately improving patient outcomes.
  • On the basis of region, North America was the leading revenue generator in 2022

RNA Targeting Small Molecule Drug Discovery Market- Segmentation Analysis:

  • The global RNA targeting small molecule drug discovery market is segmented on the basis of indication, drug, route of administration, end-user, and region.
  • The market is divided into four categories based on indication: neurological diseases, cancer, metabolic diseases, infectious disease, and others. The cancer segment is accounted to dominate the market. As they target cancer cells only and are created to specifically target cancer-related genetic alterations, RNA-targeted drugs have a cutting-edge as compared to other types of cancer treatments in terms of efficacy and side effects reduction. Moreover, for cancer treatment various pharmaceutical companies are investing heavily in RNA-targeted drug discovery, which is likely to fuel the market growth.
  • The market is categorized into six categories based on the drug: tomivosertib, translarna, risdiplam, ELX-02, ABX464, and H3B-6545. The translarna™ segment is expected to witness the largest revenue share. It is created to treat genetic disorders caused by a particular type of mutation known as a nonsense mutation. Additionally, these mutations can lead to several genetic disorders such as certain types of cystic fibrosis and muscular dystrophy. Moreover, in the mRNA Translarna™ promotes "read-through" of the premature stop codon, allowing the ribosome to continue translating and create a full-length, functional protein. This might mitigate the effects of the genetic disorder caused by the nonsense mutation.
  • The market is segmented into two categories based on the route of administration: subcutaneous and oral. The oral segment is likely to possess the largest revenue share. As it is one of the crucial preferred routes for drug delivery owing to its patient compliance and convenience. The capability to administer small molecule medications easily by oral route, avoidance of invasive procedures, and potentially improved patient adherence to treatment regimens are the advantages of developing oral delivery systems for small molecule medications.
  • The market is divided into two categories based on end-user: academic and research institutes, pharmaceutical and biopharmaceutical companies, and others. The pharmaceutical and biopharmaceutical companies segment is likely to maintain its dominance over the forecast period. As they have huge experience and resources in terms of drug discovery, and as a result, the segment is expected to continue to dominate the market. There are various small to medium-sized biopharmaceutical sectors penetrating the market.

RNA Targeting Small Molecule Drug Discovery Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

RNA Targeting Small Molecule Drug Discovery Market- Competitive Landscape:

In the competitive RNA-targeting small molecule drug discovery industry, various industries are contending for market dominance. These industries have a substantial presence on the market, based on their resources and experience in the production and development of RNA-targeted pharmaceuticals. Moreover, to introduce new treatments and get regulatory permission, they have developed connections with regulatory organizations and healthcare providers. For instance, in February 2023, ReviR Therapeutics collaborated with Asieris to develop new oncology therapies. Additionally, developing new treatments for genitourinary tumors and other related serious diseases is the aim of this collaboration.

Recent Developments:

For instance, in January 2023, Atomic AI released a $35 million series for the advancement of an AI-driven RNA structure platform for the treatment of incurable diseases.

Key features of the study:

  • This proposed research study on RNA targeting small molecule drug discovery market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The report provides the client the latest up-to-date and trending insights about the RNA targeting small molecule drug discovery market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for RNA targeting small molecule drug discovery market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the RNA targeting small molecule drug discovery market.
  • Impact of COVID-19 on RNA targeting small molecule drug discovery market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on RNA targeting small molecule drug discovery market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the RNA targeting small molecule drug discovery market, we have also included competitive landscape and key innovator analysis for the RNA targeting small molecule drug discovery market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the RNA targeting small molecule drug discovery market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global RNA targeting small molecule drug discovery market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET KEY PLAYERS

  • PTC Therapeutics
  • Accent Therapeutics
  • Expansion Therapeutics
  • Anima Biotech Inc.
  • Servier Laboratories
  • Arrakis Therapeutics
  • AstraZeneca
  • Skyhawk Therapeutics, Inc.
  • Epics Therapeutics
  • H3 Biomedicine Inc.
  • Hoffmann-La Roche Ltd
  • Ribometrix
  • AC immune
  • STORM Therapeutics

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY INDICATION

  • Neurological Diseases
  • Cancer
  • Metabolic Diseases
  • Infectious Disease
  • Others

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY DRUG

  • Tomivosertib
  • Translarna
  • Risdiplam
  • ELX-02
  • ABX464
  • H3B-6545

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY ROUTE OF ADMINISTRATION

  • Subcutaneous
  • Oral
  • Others

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY END-USER

  • Academic and Research Institutes
  • Pharmaceutical and Biopharmaceutical Companies
  • Others

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA
Show more
Product Code: ANV1608

Table of Contents

1. RNA Targeting Small Molecule Drug Discovery Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. RNA Targeting Small Molecule Drug Discovery Market Snippet by Indication
    • 2.1.2. RNA Targeting Small Molecule Drug Discovery Market Snippet by Drug
    • 2.1.3. RNA Targeting Small Molecule Drug Discovery Market Snippet by Route of Administration
    • 2.1.4. RNA Targeting Small Molecule Drug Discovery Market Snippet by End-user
    • 2.1.5. RNA Targeting Small Molecule Drug Discovery Market Snippet by Country
    • 2.1.6. RNA Targeting Small Molecule Drug Discovery Market Snippet by Region
  • 2.2. Competitive Insights

3. RNA Targeting Small Molecule Drug Discovery Key Market Trends

  • 3.1. RNA Targeting Small Molecule Drug Discovery Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. RNA Targeting Small Molecule Drug Discovery Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. RNA Targeting Small Molecule Drug Discovery Market Opportunities
  • 3.4. RNA Targeting Small Molecule Drug Discovery Market Future Trends

4. RNA Targeting Small Molecule Drug Discovery Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. RNA Targeting Small Molecule Drug Discovery Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. RNA Targeting Small Molecule Drug Discovery Market Landscape

  • 6.1. RNA Targeting Small Molecule Drug Discovery Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. RNA Targeting Small Molecule Drug Discovery Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2022&2030 (%)
    • 7.1.2. Neurological Diseases
    • 7.1.3. Cancer
    • 7.1.4. Metabolic Diseases
    • 7.1.5. Infectious Disease
    • 7.1.6. Others

8. RNA Targeting Small Molecule Drug Discovery Market - By Drug

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drug, 2022&2030 (%)
    • 8.1.2. Tomivosertib
    • 8.1.3. Translarna™
    • 8.1.4. Risdiplam
    • 8.1.5. ELX-02
    • 8.1.6. ABX464
    • 8.1.7. H3B-6545

9. RNA Targeting Small Molecule Drug Discovery Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2022&2030 (%)
    • 9.1.2. Subcutaneous
    • 9.1.3. Oral

10. RNA Targeting Small Molecule Drug Discovery Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-user, 2022&2030 (%)
    • 10.1.2. Academic and Research Institutes
    • 10.1.3. Pharmaceutical and Biopharmaceutical Companies
    • 10.1.4. Others

11. RNA Targeting Small Molecule Drug Discovery Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- RNA Targeting Small Molecule Drug Discovery Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. PTC Therapeutics
    • 12.2.2. Accent Therapeutics
    • 12.2.3. Expansion Therapeutics
    • 12.2.4. Anima Biotech Inc.
    • 12.2.5. Servier Laboratories
    • 12.2.6. Arrakis Therapeutics
    • 12.2.7. AstraZeneca
    • 12.2.8. Skyhawk Therapeutics, Inc.
    • 12.2.9. Epics Therapeutics
    • 12.2.10. H3 Biomedicine Inc.
    • 12.2.11. Hoffmann-La Roche Ltd
    • 12.2.12. Ribometrix
    • 12.2.13. AC immune
    • 12.2.14. STORM Therapeutics

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
Show more
Product Code: ANV1608

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by Indication2018-2030 (USD Million)
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: DrugSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by Drug2018-2030 (USD Million)
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: End-user Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-user
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by End-user 2018-2030 (USD Million)
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by Region 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)

List of Figures

  • FIGURE RNA Targeting Small Molecule Drug Discovery Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Indication segment market share analysis, 2022&2030
  • FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Drug segment market share analysis, 2022&2030
  • FIGURE Drug segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022&2030
  • FIGURE Route of Administrationsegment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-user segment market share analysis, 2022&2030
  • FIGURE End-user segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE Europe RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE Latin America RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe RNA Targeting Small Molecule Drug Discovery Market share analysis by country, 2022
  • FIGURE Germany RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market share analysis by country, 2022
  • FIGURE India RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America RNA Targeting Small Molecule Drug Discovery Market share analysis by country, 2022
  • FIGURE Brazil RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market share analysis by country, 2022
  • FIGURE Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!